These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28458356)

  • 1. Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin's Lymphoma.
    Hayashi H; Suzuki A; Ohata K; Ishihara M; Kubota Y; Kobayashi R; Shibata Y; Nakamura H; Nakamura N; Kitagawa J; Tsurumi H; Shimizu M; Itoh Y
    Biol Pharm Bull; 2017; 40(5):698-702. PubMed ID: 28458356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
    Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
    Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
    Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F
    Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antacid attenuates the laxative action of magnesia in cancer patients receiving opioid analgesic.
    Ibuka H; Ishihara M; Suzuki A; Kagaya H; Shimizu M; Kinosada Y; Itoh Y
    J Pharm Pharmacol; 2016 Sep; 68(9):1214-21. PubMed ID: 27364763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.
    Miller TP; Dahlberg S; Cassady JR; Adelstein DJ; Spier CM; Grogan TM; LeBlanc M; Carlin S; Chase E; Fisher RI
    N Engl J Med; 1998 Jul; 339(1):21-6. PubMed ID: 9647875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
    Limat S; Daguindau E; Cahn JY; Nerich V; Brion A; Perrin S; Woronoff-Lemsi MC; Deconinck E
    J Clin Pharm Ther; 2014 Apr; 39(2):168-74. PubMed ID: 24384030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma.
    Szmit S; Jurczak W; Zaucha JM; Drozd-Sokołowska J; Spychałowicz W; Joks M; Długosz-Danecka M; Torbicki A
    J Am Soc Hypertens; 2014 Nov; 8(11):791-9. PubMed ID: 25455004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.
    Picozzi VJ; Pohlman BL; Morrison VA; Lawless GD; Lee MW; Kerr RO; Ford JM; Delgado DJ; Fridman M; Carter WB
    Oncology (Williston Park); 2001 Oct; 15(10):1296-306; discussion 1310-1, 1314. PubMed ID: 11702959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
    Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side effects of CHOP in the treatment of non-hodgkin's lymphoma.
    Sitzia J; North C; Stanley J; Winterberg N
    Cancer Nurs; 1997 Dec; 20(6):430-9. PubMed ID: 9409065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age and colony-stimulating factor use on hospital length of stay for febrile neutropenia in CHOP-treated non-Hodgkin's lymphoma.
    Chrischilles E; Delgado DJ; Stolshek BS; Lawless G; Fridman M; Carter WB
    Cancer Control; 2002; 9(3):203-11. PubMed ID: 12060818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of elderly patients with non-Hodgkin's lymphoma].
    Titorenko IB; Kriachok IA
    Lik Sprava; 2011; (5-6):79-85. PubMed ID: 22606896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma.
    Chrischilles EA; Link BK; Scott SD; Delgado DJ; Fridman M
    Cancer Control; 2003; 10(5):396-403. PubMed ID: 14581895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
    Yuan ZY; Xu RH; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of optimal CHOP dose ranges for elderly patients with non-Hodgkin's lymphoma].
    Mori M; Murai Y; Suzuki K; Nonaka Y; Sato H; Tomiyama J; Takagi T; Muto Y; Kashimura M
    Rinsho Ketsueki; 1999 Mar; 40(3):199-204. PubMed ID: 10222626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of R-CHOP/CHOP therapy-induced nausea and vomiting in non-Hodgkin's lymphoma patients: a comparison of intravenous and oral 5-HT3 receptor antagonists.
    Takahashi T; Kumanomidou S; Takami S; Okada T; Adachi K; Jo Y; Ikejiri F; Onishi C; Kawakami K; Miyake T; Inoue M; Moriyama I; Suzuki R; Suzumiya J
    Int J Hematol; 2016 Sep; 104(3):378-83. PubMed ID: 27312042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.
    Meyer RM; Browman GP; Samosh ML; Benger AM; Bryant-Lukosius D; Wilson WE; Frank GL; Leber BF; Sternbach MS; Foster GA
    J Clin Oncol; 1995 Sep; 13(9):2386-93. PubMed ID: 7666098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.